The VXX is downgraded to a "Sell" amid bearish trends and volatility decay. Here's what investors need to keep in mind.
For all the attention paid to the dollar’s changing correlation to the level of US stocks this year, Goldman Sachs Group Inc ...
Viking Therapeutics is a clinical-stage biopharmaceutical company that specializes in developing novel therapies for metabolic and endocrine disorders. Here's what investors should know.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback